Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
Clinical trial NCT00205816 · COMPLETED
Trial details
- NCT number
- NCT00205816
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2005-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.